You are here

Genomic Applications Partnership Program

Program Overview

The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects that address real world opportunities and challenges identified by industry, government, not-for-profits and other “Receptors” of genomics knowledge and technologies. GAPP projects are collaborations between academic researchers and Receptor organizations, and are co-funded by Genome Canada, Receptors and other stakeholders.

To be eligible for GAPP funding, projects must:

  • develop and apply a genomics-derived tool, product or process to an opportunity or need defined by the Receptor(s);
  • focus on late stage R&D that will position the innovation for near term implementation / commercialization;
  • be co-led by an Academic and a Receptor organization in partnership, with active and necessary roles for both (see GAPP Investment Strategy and Guidelines for GAPP project partner definitions); and,
  • have the potential to generate significant social and/or economic benefits for Canada (see Section 6 for description of benefits to Canada).

Applicants can request up to 1/3 of the project budget from Genome Canada, from a minimum contribution of $100,000 to a maximum of $2 million. The remaining project funding must be secured from other eligible sources, with at least 1/3 provided by the Receptor(s). The duration of GAPP projects should be a minimum of one year to a maximum of three years, but may be shorter or longer if justified.

All applications to GAPP must be submitted via a regional Genome Centre. Please contact your regional Genome Centre for more information.

GAPP Round 19 Update (February 2020)

The Genomic Applications Partnership Program (GAPP) represents a key element in Genome Canada’s mandate – funding downstream research and development (R&D) projects that address real world opportunities and challenges identified by industry, government, not-for-profits and other “Receptors” of genomics knowledge and technologies. The GAPP was launched in 2013 and since the program’s inception the total investment has been over $286 million of which Genome Canada has provided over $89 million over the course of 16 rounds of funding.  

Based on the current rate of funding per round, it is anticipated that there will be sufficient funds to support projects up to and including Round 19. In order to be as accommodating as possible with available funds, we have decided to reschedule the funding decision for Round 19 from Genome Canada’s September 2020 Board of Directors meeting to December 2020. 

As the GAPP is an important element of Genome Canada’s suite of programs, we are exploring opportunities to secure additional funding for future rounds. 

Please contact your regional Genome Centre for more information on the impact of rescheduling Round 19 on their deadlines and for news on future rounds as it becomes available.